Concepedia

Changjun He

CH

15

Publications

949

Citations

14

H-Index

2010

Active since

Affiliations

Harbin Medical University(Current)

Third Affiliated Hospital of Harbin Medical University

First Affiliated Hospital of Harbin Medical University

Fourth Affiliated Hospital of Harbin Medical University

University of Auckland

Changjun He is an author at Harbin Medical University specializing in tumor biology, tumor microenvironment, and medicine.

ORCID

Top concepts

Publications per year

2010–2021

15

Publications

15

MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway

Changjun He, Xuesong Dong, Bo Zhai et al. · Oncotarget · 2015 · 213 citations · Full text

LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

Weidong Li, Xuesong Dong, Changjun He et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 202 citations · Full text

Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells

Dali Zhao, Bo Zhai, Changjun He et al. · Cellular Signalling · 2014 · 137 citations · Full text

Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma

Changjun He, Xuepu Sun · Cancer Science · 2011 · 64 citations · Full text

, , +25

LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis

Huaqiang Zhu, Bo Zhai, Changjun He et al. · Cell Death and Disease · 2020 · 54 citations · Full text

Rows per page

1–5 of 15